Condensed Consolidated Statement of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024
Cash Flows from Operating Activities
Net loss	$ (1,751,977)	$ (2,928,154)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	55,262	171,771
Stock based compensation, including amortization of deferred equity compensation	12,393	180,168
Gain on change in fair value of derivative financial instruments	(45,732)
Amortization of debt discount	619,693	479,621
(Gain) loss on extinguishment of debt	(174,972)	170,227
Change in fair value of debt	154,688	(27,900)
Gain from realization of contingent sale consideration receivable		(711)
Changes in operating assets and liabilities:
Accounts receivable		(17,698)
Inventory	17,097	36,792
Contract assets	9,381
Prepaid expenses and other current assets	29,461	20,468
Right of use lease assets	122,121	165,264
Accounts payable and accrued expenses	302,982	189,591
Lease liability	(123,153)	(165,427)
Contract liabilities	(77,333)	12,439
Net cash used in operating activities	(850,089)	(1,713,549)
Cash Flows from Investing Activities
Acquisition of property and equipment		(2,598)
Net cash used in investing activities		(2,598)
Cash Flows from Financing Activities
Proceeds from sale of common stock	10,000	405,000
Proceeds from related party notes payable	710,000	1,650,000
Proceeds from third party notes payable	305,000	135,000
Repayment of related party notes payable		(37,602)
Repayment of third party notes payable	(230,951)	(510,773)
Net cash provided by financing activities	794,049	1,641,625
Net decrease in cash	(56,040)	(74,522)
Cash, beginning of period	76,241	247,222
Cash, end of period	20,201	172,700
Supplemental disclosure of cash flow information:
Cash paid during the period for interest	13,158	13,158
Cash paid during the period for income tax
Schedule of non-cash investing and financing activities:
Recognition of operating lease: right of use asset and lease liability	29,997	28,044
Extinguishment of operating lease: right of use asset and lease liability	(115,172)
Fair value of options issued in satisfaction of common stock issuable		283,869
Fair value of warrants allocated to proceeds of related party notes payable		552,848
Fair value of derivative financial instruments allocated to proceeds of third party notes payable	62,017
Fair value of beneficial conversion feature allocated to proceeds of related party notes payable	58,724	539,310
Original issue discounts allocated to proceeds of notes payable	113,002
Fair value of warrants issued to extend related party debt	47,751	21,518
Principal amount of convertible notes payable to related party refinanced	2,981,500
Principal amount of undocumented advances converted to convertible note payable to related party	420,000
Incremental fair value of convertible note payable to related party resulting from refinancing	11,607	88,127
Fair value of shares issued for equity issuance costs	6,000
Accrued interest included in fair value of note payable	234,329	8,712
Accounts payable included in principal balance of notes payable to related party	$ 27,692

HealthLynked Corp 10-Q